Wagner, 1987 - Google Patents

Scientific highlights:“slices of life”

Wagner, 1987

View PDF @Free from Publisher
Document ID
4637842461450016026
Author
Wagner H
Publication year
Publication venue
Journal of Nuclear Medicine

External Links

Snippet

The 34th Annual Meeting of The Soci ety of Nuclear Medicine (SNM), held last June in Toronto, Canada,/narked the 10th anniversary of the Scientific Meeting Highlights given by Henry N. Wagner, Jr., MD. During this closing session, which has become a Society …
Continue reading at jnm.snmjournals.org (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Carlin et al. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers
Sasaki et al. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver
JP5998171B2 (en) Method for detecting heart failure
Werner et al. The changing face of nuclear cardiology: guiding cardiovascular care toward molecular medicine
Werner et al. Recent paradigm shifts in molecular cardiac imaging—Establishing precision cardiology through novel 18F-labeled PET radiotracers
Mastrocola et al. Update of the Brazilian guideline on nuclear cardiology-2020
Schomäcker et al. Use of myocardial imaging agents for tumour diagnosis–a success story?
Burman et al. Management of patients with thyroid carcinoma: application of thallium-201 scintigraphy and magnetic resonance imaging
Pelletier-Galarneau et al. Molecular imaging of cardiac amyloidosis
Naito et al. Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan
Manrique et al. Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy
Kalinin et al. The parathyroid glands: imaging and surgery
Wagner Scientific highlights:“slices of life”
EP2882863B1 (en) System and method for quantitative mapping of mitocondrial complex 1
Emren et al. Evaluation of Trastuzumab-induced early cardiac dysfunction using two-dimensional Strain Echocardiography.
Wagner Oncology: a new engine for PET/SPECT
Qin et al. Noninvasive diagnosis of hereditary transthyretin-related cardiac amyloidosis: A case report
Minamihaba et al. Pulsed Doppler tissue imaging for the assessment of myocardial viability: comparison with 99mTc sestamibi perfusion imaging
RU2800818C1 (en) Method of breast cancer diagnostics with her2/neu hyperexpression
Horblitt Amyloid Imaging
Liu et al. 111 In—antimyosin antibody imaging for detection of myocardial infarction: a quantitative approach
Neumann et al. Imaging in parathyroid diseases
Giordano et al. Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy
Chaaban et al. The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis
Lee et al. Global and Regional Variations in Transthyretin Cardiac Amyloidosis: A Comparison of Longitudinal Strain and 99mTechnetium Pyrophosphate Imaging